Based on Fortune Business Insights’ report, the Alzheimer’s drugs market share sector attained a worth of USD 3.52 billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 5.1% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of USD 5.21 billion by 2030, highlighting considerable opportunities within this flourishing […]


